toggle visibility Search & Display Options

Select All    Deselect All
 | 
Citations
 | 
   print
Thomas, A. A., Abrey, L. E., Terziev, R., Raizer, J., Martinez, N. L., Forsyth, P., et al. (2017). Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma. Neuro Oncol, 19(10), 1380–1390.
toggle visibility
Oliva, C. R., Zhang, W., Langford, C., Suto, M. J., & Griguer, C. E. (2017). Repositioning chlorpromazine for treating chemoresistant glioma through the inhibition of cytochrome c oxidase bearing the COX4-1 regulatory subunit. Oncotarget, 8(23), 37568–37583.
toggle visibility
Kim, M. Y., Park, S. - J., Shim, J. W., Song, Y. J., Yang, K., Park, S. - J., et al. (2017). Accumulation of low-dose BIX01294 promotes metastatic potential of U251 glioblastoma cells. Oncol Lett, 13(3), 1767–1774.
toggle visibility
Shahar, T., Rozovski, U., Hess, K. R., Hossain, A., Gumin, J., Gao, F., et al. (2017). Percentage of mesenchymal stem cells in high-grade glioma tumor samples correlates with patient survival. Neuro Oncol, 19(5), 660–668.
toggle visibility
Roy, A., Attarha, S., Weishaupt, H., Edqvist, P. - H., Swartling, F. J., Bergqvist, M., et al. (2017). Serglycin as a potential biomarker for glioma: association of serglycin expression, extent of mast cell recruitment and glioblastoma progression. Oncotarget, 8(15), 24815–24827.
toggle visibility
Select All    Deselect All
 | 
Citations
 | 
   print